인쇄하기
취소
|
Facing the enforcement of the ‘Anti-Corruption and Bribery Prohibition Law,’ also known as ‘Kim Young-ran Law,’ on the 28th of September, the pharmaceutical industry is giving the best on its advanced prevention, such as tightening the Compliance Program management.
The pharmaceutical distribution industry, on the other hand, is known to have no particular preparation for it while there is le...